Delivery Order SPE2DR25D1017-SPE2DR26F9APP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60 count) on August 4, 2025, with a ceiling value of $40,373.44. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 5, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count packages) on November 7, 2025, with a ceiling value of $1,563.52 and an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,710.26 to AmerisourceBergen Drug Corp for 60 tablets of MULTAQ 400 mg on December 9, 2025, with completion expected by December 10, 2025. This competitive award, which utilized firm fixed pricing with no set-aside designation, represents a pharmaceutical supply delivery to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 21, 2025, for the supply of MULTAQ 400 mg tablets (60-count) with a ceiling value of $2,039.84. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by May 22, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of MULTAQ 400 mg tablets (60-count units) with a ceiling value of $11,894.31. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The order is due for completion by September 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) on October 22, 2025, with a ceiling value of $8,234.43 and an ultimate completion date of October 23, 2025. This competitively awarded, firm fixed-price delivery order represents a single pharmaceutical procurement under AmerisourceBergen's broader relationship with DLA's medical supply chain. The contract involved no set-aside designation, indicating open competition...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $5,337.74. This firm fixed-price delivery order is scheduled for completion by December 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively made with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,477.84 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of MULTAQ 400 mg tablets (60-count packages). This firm fixed price delivery order, which must be completed by November 7, 2025, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count) under a firm fixed-price contract valued at $3,059.76. The order was competitively awarded without set-aside designation and is scheduled for completion by July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this pharmaceutical delivery from its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $44,277.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 mg tablets (60-count units) on November 6, 2025, with an ultimate completion date of November 7, 2025. This contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9APPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of MULTAQ 400 mg tablets in a 60-count package, with a contract ceiling value of $6,017.84. This is a firm fixed-price delivery order with an ultimate completion date of December 2, 2025, issued under a non-competitive, non-set-aside procurement. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply delivery supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. As a prime IDC vehicle, this comprehensive contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. The company's consistent receipt of competitively awarded delivery orders demonstrates its established capability to fulfill federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 11/30/25 |